Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes. There has been recent recognition of the limitations of hemoglobin A1C (HbA1C) in describing both short- and long-term glycemic control. Continuous glucose monitoring (CGM) provides robust data about short-term glycemic control and provides metrics such as percent time-in-range (%TIR) that are now routinely reported to describe the change in glycemic control after an intervention in a clinical study or a change in therapy in a patient's care. Recent studies have shown that %TIR may have similar associations with diabetes microvascular complications as does HbA1C. The relationship of %TIR to the long-standing metric of overall glycemic control has not been clearly defined to date. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetes technology & therapeutics Pubmed

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.

Diabetes technology & therapeutics , Volume 21 (2): 5 – Jul 25, 2019

The Relationship of Hemoglobin A1C to Time-in-Range in Patients with Diabetes.


Abstract

There has been recent recognition of the limitations of hemoglobin A1C (HbA1C) in describing both short- and long-term glycemic control. Continuous glucose monitoring (CGM) provides robust data about short-term glycemic control and provides metrics such as percent time-in-range (%TIR) that are now routinely reported to describe the change in glycemic control after an intervention in a clinical study or a change in therapy in a patient's care. Recent studies have shown that %TIR may have similar associations with diabetes microvascular complications as does HbA1C. The relationship of %TIR to the long-standing metric of overall glycemic control has not been clearly defined to date.

Loading next page...
 
/lp/pubmed/the-relationship-of-hemoglobin-a1c-to-time-in-range-in-patients-with-S8K9f0qtfp

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

eISSN
1557-8593
DOI
10.1089/dia.2018.0310
pmid
30575414

Abstract

There has been recent recognition of the limitations of hemoglobin A1C (HbA1C) in describing both short- and long-term glycemic control. Continuous glucose monitoring (CGM) provides robust data about short-term glycemic control and provides metrics such as percent time-in-range (%TIR) that are now routinely reported to describe the change in glycemic control after an intervention in a clinical study or a change in therapy in a patient's care. Recent studies have shown that %TIR may have similar associations with diabetes microvascular complications as does HbA1C. The relationship of %TIR to the long-standing metric of overall glycemic control has not been clearly defined to date.

Journal

Diabetes technology & therapeuticsPubmed

Published: Jul 25, 2019

There are no references for this article.